$CDLX
Cardlytics, Inc. Stock $cdlx

$cdlx Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000166607122000059 Filed on May 02, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q1
Revenue	$75.41M	$67.93M	$53.23M
YoY Change	28.12%	27.61%	16.97%
Cost Of Revenue	$40.28M	$34.27M	$29.77M
YoY Change	37.84%	15.12%	13.89%
Gross Profit	$35.13M	$33.66M	$23.46M
YoY Change	18.55%	43.47%	21.12%
Gross Profit Margin	46.58%	49.55%	44.07%
Selling, General & Admin	$42.97M	$38.07M	$25.38M
YoY Change	26.56%	50.03%	16.88%
% of Gross Profit	122.33%	113.12%	108.17%
Research & Development	$13.58M	$12.29M	$6.218M
YoY Change	52.01%	97.67%	61.46%
% of Gross Profit	38.66%	36.52%	26.5%
Depreciation & Amortization	$10.36M	$9.871M	$3.065M
YoY Change	17.31%	222.06%	30.48%
% of Gross Profit	29.48%	29.33%	13.06%
Operating Expenses	$56.55M	$50.36M	$31.60M
YoY Change	31.86%	59.4%	23.6%
Operating Profit	-$122.3M	$35.66M	-$22.17M
YoY Change	176.56%	-260.84%	85.84%
Interest Expense	-$5.417M	-$2.618M	-$3.050M
YoY Change	75.99%	-14.16%	90.63%
% of Operating Profit		-7.34%
Other Income/Expense, Net	-$5.417M	-$2.618M	-$2.726M
YoY Change	75.99%	-3.96%	70.16%
Pretax Income	-$127.7M	$33.04M	-$24.90M
YoY Change	170.02%	-232.71%	83.98%
Income Tax	-$1.446M	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$126.3M	$33.04M	-$24.90M
YoY Change	166.96%	-232.71%	83.98%
Net Earnings / Revenue	-167.48%	48.64%	-46.77%
Basic Earnings Per Share	-$3.75	$0.98	-$0.85
Diluted Earnings Per Share	-$3.75	$0.91	-$0.85
COMMON SHARES
Basic Shares Outstanding	34.12M shares	33.74M shares	29.31M shares
Diluted Shares Outstanding	33.64M shares	37.19M shares	29.31M shares

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$157.0M	$208.3M	$613.5M
YoY Change	-37.34%	-66.05%	500.29%
Cash & Equivalents	$157.0M	$208.3M	$613.5M
Short-Term Investments
Other Short-Term Assets	$9.739M	$8.901M	$7.800M
YoY Change	18.15%	14.12%	27.87%
Inventory
Prepaid Expenses
Receivables	$92.21M	$96.53M	$75.33M
Other Receivables	$4.955M	$5.717M	$5.911M
Total Short-Term Assets	$263.9M	$319.4M	$702.6M
YoY Change	-22.02%	-54.53%	313.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.619M	$9.909M	$14.12M
YoY Change	-34.18%	-29.81%	7.89%
Goodwill	$665.8M	$747.6M	$203.2M
YoY Change	-7.33%	267.94%
Intangibles	$121.0M	$128.3M	$78.98M
YoY Change	-11.76%	62.38%	19449.75%
Long-Term Investments
YoY Change
Other Assets	$3.106M	$2.638M	$2.681M
YoY Change	18.69%	-1.6%	36.65%
Total Long-Term Assets	$825.6M	$911.7M	$320.5M
YoY Change	-7.7%	184.51%	789.28%
TOTAL ASSETS
Total Short-Term Assets	$263.9M	$319.4M	$702.6M
Total Long-Term Assets	$825.6M	$911.7M	$320.5M
Total Assets	$1.090B	$1.231B	$1.023B
YoY Change	-11.63%	20.35%	396.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.810M	$3.839M	$3.249M
YoY Change	-46.14%	18.16%	183.51%
Accrued Expenses	$20.96M	$14.63M	$8.714M
YoY Change	155.43%	67.9%	190.18%
Deferred Revenue	$4.654M	$3.122M	$259.0K
YoY Change	67.59%	1105.41%	-57.05%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$37.00K	$36.00K	$7.000K
YoY Change	60.87%	414.29%	-70.83%
Total Short-Term Liabilities	$293.5M	$246.8M	$92.04M
YoY Change	11.62%	168.14%	57.58%
LONG-TERM LIABILITIES
Long-Term Debt	$225.3M	$225.0M	$176.5M
YoY Change	25.78%	27.47%	2521328.57%
Other Long-Term Liabilities	$28.00K	$4.037M	$679.0K
YoY Change	-95.88%	494.55%	-92.7%
Total Long-Term Liabilities	$28.00K	$4.037M	$679.0K
YoY Change	-95.88%	494.55%	9600.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$293.5M	$246.8M	$92.04M
Total Long-Term Liabilities	$28.00K	$4.037M	$679.0K
Total Liabilities	$525.4M	$519.5M	$278.1M
YoY Change	1.33%	86.78%	310.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$604.6M	-$478.3M	-$418.9M
YoY Change	29.66%	14.16%	18.96%
Common Stock	$1.163B	$1.188B	$1.164B
YoY Change	-1.54%	2.04%	138.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$564.2M	$711.7M	$744.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.090B	$1.231B	$1.023B
YoY Change	-11.63%	20.35%	396.43%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$126.3M	$33.04M	-$24.90M
YoY Change	166.96%	-232.71%	83.98%
Depreciation, Depletion And Amortization	$10.36M	$9.871M	$3.065M
YoY Change	17.31%	222.06%	30.48%
Cash From Operating Activities	-$6.678M	-$19.69M	-$12.53M
YoY Change	-55.42%	57.13%	267.94%
INVESTING ACTIVITIES
Capital Expenditures	-$4.269M	$397.0K	$1.377M
YoY Change	44.76%	-71.17%	179.88%
Acquisitions		$2.274M	$148.6M
YoY Change		-98.47%
Other Investing Activities	$0.00	-$2.274M	-$148.6M
YoY Change	-100.0%	-98.47%
Cash From Investing Activities	-$4.269M	-$5.034M	-$152.0M
YoY Change	-98.77%	-96.69%	10474.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$40.00M	$195.0K	$484.7M
YoY Change		-99.96%	15312.18%
Debt Paid & Issued, Net		$13.00K	$6.000K
YoY Change		116.67%	0.0%
Cash From Financing Activities	-39.98M	$182.0K	$484.7M
YoY Change	-5554.84%	-99.96%	15340.11%
NET CHANGE
Cash From Operating Activities	-6.678M	-$19.69M	-$12.53M
Cash From Investing Activities	-4.269M	-$5.034M	-$152.0M
Cash From Financing Activities	-39.98M	$182.0K	$484.7M
Net Change In Cash	-50.93M	-$25.18M	$320.3M
YoY Change	-85.96%	-107.86%	-14075.13%
FREE CASH FLOW
Cash From Operating Activities	-$6.678M	-$19.69M	-$12.53M
Capital Expenditures	-$4.269M	$397.0K	$1.377M
Free Cash Flow	-$2.409M	-$20.09M	-$13.91M
YoY Change	-79.98%	44.42%	256.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001666071
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-38386
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	CARDLYTICS, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3039436
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Ponce de Leon Ave. NE, Ste 6000
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30308
CY2022Q1	dei	City Area Code CityAreaCode	(888)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	792-5802
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2022Q1	dei	Trading Symbol TradingSymbol	CDLX
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34115110	shares
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	233467000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	208293000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	95000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	92000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	111085000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	96529000	USD
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6097000	USD
CY2022Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5717000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7981000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8809000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	358725000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	319440000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11273000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9909000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10196000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9249000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	125550000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	128250000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	742516000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	747578000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	13131000	USD
CY2022Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	14115000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2406000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2638000	USD
CY2021Q4	us-gaap	Assets Assets	1263797000	USD
CY2022Q1	us-gaap	Assets Assets	1231179000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4619000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3839000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12136000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7910000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19620000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14631000	USD
CY2021Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	46595000	USD
CY2022Q1	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	36995000	USD
CY2021Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	52602000	USD
CY2022Q1	cdlx	Customer Incentive Liability CustomerIncentiveLiability	45098000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3280000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3122000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6028000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6249000	USD
CY2021Q4	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	182470000	USD
CY2022Q1	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	128941000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	327350000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	246785000	USD
CY2021Q4	us-gaap	Senior Notes SeniorNotes	184398000	USD
CY2022Q1	us-gaap	Senior Notes SeniorNotes	224948000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6801000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5268000	USD
CY2021Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	173000	USD
CY2022Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	167000	USD
CY2021Q4	cdlx	Contingent Consideration Liability Long Term ContingentConsiderationLiabilityLongTerm	49825000	USD
CY2022Q1	cdlx	Contingent Consideration Liability Long Term ContingentConsiderationLiabilityLongTerm	38304000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4550000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4037000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	573097000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	519509000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33534000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33534000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33790000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33790000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1212823000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1188076000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	486000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1853000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-522618000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-478268000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	690700000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	711670000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1263797000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1231179000	USD
CY2021Q1	us-gaap	Revenues Revenues	53230000	USD
CY2022Q1	us-gaap	Revenues Revenues	67928000	USD
CY2021Q1	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	29771000	USD
CY2022Q1	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	35153000	USD
CY2021Q1	cdlx	Delivery Costs DeliveryCosts	3938000	USD
CY2022Q1	cdlx	Delivery Costs DeliveryCosts	6533000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13202000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17648000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6218000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12291000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12175000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20425000	USD
CY2021Q1	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	7030000	USD
CY2022Q1	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-4599000	USD
CY2021Q1	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	0	USD
CY2022Q1	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-65050000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3065000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9871000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	75399000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	32272000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-22169000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	35656000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3045000	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-947000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	319000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1671000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2726000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2618000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24895000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33038000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-24895000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	33038000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24895000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	33038000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.98
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29313000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33741000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29313000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37185000	shares
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-24895000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	33038000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-296000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1367000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25191000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	34405000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	690700000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	195000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14538000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	11937000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1367000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	33038000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	711670000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	157192000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	507000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7394000	USD
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3850000	shares
CY2022Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	484043000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	117354000	USD
CY2021Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	3593000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-296000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-24895000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	744892000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-24895000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	33038000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1004000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	346000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3065000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9871000	USD
CY2021Q1	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	219000	USD
CY2022Q1	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	402000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2321000	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1073000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1516000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7248000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	13585000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-65050000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	141000	USD
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1574000	USD
CY2021Q1	cdlx	Contract With Customer Asset Deferred Implementation Costs ContractWithCustomerAssetDeferredImplementationCosts	882000	USD
CY2022Q1	cdlx	Contract With Customer Asset Deferred Implementation Costs ContractWithCustomerAssetDeferredImplementationCosts	0	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7867000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15279000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1845000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	725000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	495000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-855000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	996000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-11569000	USD
CY2021Q1	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-6749000	USD
CY2022Q1	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-9600000	USD
CY2021Q1	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-4072000	USD
CY2022Q1	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-7503000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12532000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19691000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1377000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	397000	USD
CY2021Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	28000	USD
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	49000	USD
CY2021Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1923000	USD
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2314000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	148634000	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2274000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-151962000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5034000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	484713000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	195000	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	42000	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	484665000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	182000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	139000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-634000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	320310000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25177000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293349000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233562000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	613659000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208385000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	613548000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	208293000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	111000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	92000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	613659000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208385000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1120000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1169000	USD
CY2021Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	190000	USD
CY2022Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2021Q1	cdlx	Noncash Or Part Noncash Acquisition Accrued Consideration NoncashOrPartNoncashAcquisitionAccruedConsideration	117354000	USD
CY2022Q1	cdlx	Noncash Or Part Noncash Acquisition Accrued Consideration NoncashOrPartNoncashAcquisitionAccruedConsideration	0	USD
CY2021Q1	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	102000	USD
CY2022Q1	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	29000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, stock-based compensation, allowance for doubtful accounts, valuation of acquired intangible assets, valuation of contingent consideration for Bridg, income tax including valuation allowance and contingencies. We base our estimates on historical experience and on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates.</span></div>
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10196000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9249000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	86000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	75000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	10282000	USD
CY2021Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	9324000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6028000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6249000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6801000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5268000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	36000	USD
CY2021Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	36000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	50000	USD
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	36000	USD
CY2021Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	12915000	USD
CY2021Q1	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	11589000	USD
CY2021Q1	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	7000000	USD
CY2022Q1	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-4600000	USD
CY2022Q1	cdlx	Business Combination Proforma Information Revenue Of Acquiree Since Acquisition Date Actual Percent BusinessCombinationProformaInformationRevenueOfAcquireeSinceAcquisitionDateActualPercent	0.03
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2021Q4	us-gaap	Goodwill Goodwill	742516000	USD
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5062000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	747578000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	154500000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26857000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	127643000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7100000	USD
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	85140
CY2020Q3	cdlx	Debt Instrument Required Compliance Period Period After Written Notice DebtInstrumentRequiredCompliancePeriodPeriodAfterWrittenNotice	P60D
CY2020Q3	cdlx	Debt Instrument Convertible Redemption Period Days Before Maturity Date DebtInstrumentConvertibleRedemptionPeriodDaysBeforeMaturityDate	P36D
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	21571000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	28695000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	27976000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	27336000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	17596000	USD
CY2022Q1	cdlx	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	4469000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	127643000	USD
CY2021Q1	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	23100000	USD
CY2022Q1	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	30300000	USD
CY2022Q1	cdlx	Debt Instrument Convertible Threshold Principal Outstanding Amount For Partial Redemption DebtInstrumentConvertibleThresholdPrincipalOutstandingAmountForPartialRedemption	75000000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53230000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63983000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	78000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	65000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1800000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1467000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	18000000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10200000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2020Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	USD
CY2020Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	222700000	USD
CY2020Q3	cdlx	Adjustments To Additional Paid In Capital Issuance Of Capped Calls AdjustmentsToAdditionalPaidInCapitalIssuanceOfCappedCalls	26500000	USD
CY2020Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	10000	numberOfDays
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.98
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	11.7457
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2020Q3	cdlx	Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance	0.25
CY2020Q3	cdlx	Debt Instrument Convertible Redemption Requirement Amount Of Other Debt Called Due DebtInstrumentConvertibleRedemptionRequirementAmountOfOtherDebtCalledDue	35000000	USD
CY2020Q3	cdlx	Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance	0.25
CY2022Q1	cdlx	Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance	0.25
CY2022Q1	cdlx	Debt Instrument Convertible Covenant Noncompliance Period Of Additional Interest DebtInstrumentConvertibleCovenantNoncompliancePeriodOfAdditionalInterest	P365D
CY2022Q1	cdlx	Debt Instrument Convertible Liability Component Discount Rate DebtInstrumentConvertibleLiabilityComponentDiscountRate	0.0650
CY2021Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	575000	USD
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	575000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2321000	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	207000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	365000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3103000	USD
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	940000	USD
CY2020Q3	cdlx	Adjustments To Additional Paid In Capital Issuance Of Capped Calls AdjustmentsToAdditionalPaidInCapitalIssuanceOfCappedCalls	26500000	USD
CY2020Q3	us-gaap	Option Indexed To Issuers Equity Strike Price1 OptionIndexedToIssuersEquityStrikePrice1	85.14
CY2020Q3	cdlx	Option Indexed To Issuers Equity Cap Price OptionIndexedToIssuersEquityCapPrice	128.51
CY2022Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2022Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	50000000	USD
CY2022Q1	cdlx	Line Of Credit Facility Maximum Borrowing Capacity Percentage Of Eligible Accounts Receivable LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleAccountsReceivable	0.85
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2033227	shares
CY2022Q1	cdlx	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Annual Percentage Increase ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAnnualPercentageIncrease	0.05
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1676682	shares
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7248000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13585000	USD
CY2021Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	100000	USD
CY2022Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	200000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2022Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	54.98
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2701000	shares
CY2022Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	54.98
CY2022Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	54.98
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	3785000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	0	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-882000	USD
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	0	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	2903000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	0	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24895000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	33038000	USD
CY2021Q1	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2022Q1	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	940000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24895000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	33978000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29313000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33741000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29313000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37185000	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021Q1	cdlx	Adjusted Contribution AdjustedContribution	24341000	USD
CY2022Q1	cdlx	Adjusted Contribution AdjustedContribution	32775000	USD
CY2021Q1	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	28889000	USD
CY2022Q1	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	35153000	USD
CY2021Q1	us-gaap	Revenues Revenues	53230000	USD
CY2022Q1	us-gaap	Revenues Revenues	67928000	USD
CY2021Q1	cdlx	Adjusted Contribution AdjustedContribution	24341000	USD
CY2022Q1	cdlx	Adjusted Contribution AdjustedContribution	32775000	USD
CY2021Q1	cdlx	Contract With Customer Asset Deferred Implementation Costs Amortization ContractWithCustomerAssetDeferredImplementationCostsAmortization	882000	USD
CY2022Q1	cdlx	Contract With Customer Asset Deferred Implementation Costs Amortization ContractWithCustomerAssetDeferredImplementationCostsAmortization	0	USD
CY2021Q1	cdlx	Delivery Costs DeliveryCosts	3938000	USD
CY2022Q1	cdlx	Delivery Costs DeliveryCosts	6533000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13202000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17648000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6218000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12291000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12175000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20425000	USD
CY2021Q1	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	7030000	USD
CY2022Q1	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-4599000	USD
CY2021Q1	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	0	USD
CY2022Q1	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-65050000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3065000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9871000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2726000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2618000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24895000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33038000	USD
CY2021Q1	us-gaap	Revenues Revenues	53230000	USD
CY2022Q1	us-gaap	Revenues Revenues	67928000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11273000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9909000	USD

Files In Submission

Name	View Source	Status
0001666071-22-000059-index-headers.html	Edgar Link	pending
0001666071-22-000059-index.html	Edgar Link	pending
0001666071-22-000059.txt	Edgar Link	pending
0001666071-22-000059-xbrl.zip	Edgar Link	pending
cdlx-20220331.htm	Edgar Link	pending
cdlx-20220331.xsd	Edgar Link	pending
cdlx-20220331_cal.xml	Edgar Link	unprocessable
cdlx-20220331_def.xml	Edgar Link	unprocessable
cdlx-20220331_g1.jpg	Edgar Link	pending
cdlx-20220331_htm.xml	Edgar Link	completed
cdlx-20220331_lab.xml	Edgar Link	unprocessable
cdlx-20220331_pre.xml	Edgar Link	unprocessable
cdlx_form10-qx2022q1xex311.htm	Edgar Link	pending
cdlx_form10-qx2022q1xex312.htm	Edgar Link	pending
cdlx_form10-qx2022q1xex321.htm	Edgar Link	pending
cdlx_formx10-qx2022q1xex101.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDLX
Cardlytics, Inc. Stock $cdlx

2022 Q2 Form 10-Q Financial Statement

#000166607122000059 Filed on May 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX Cardlytics, Inc. Stock $cdlx

2022 Q2 Form 10-Q Financial Statement

#000166607122000059 Filed on May 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX
Cardlytics, Inc. Stock $cdlx